Lester W J Tan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Lester W J Tan

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

NPJ Digital Medicine|August 27, 2024

Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.

Bioengineering & Translational Medicine|May 19, 2025

AI-assisted warfarin dose optimisation with CURATE.AI for clinical impact: Retrospective data analysisTiffany Rui Xuan Gan, Lester W J Tan, Mathias Egermark, et al.

NPJ Precision Oncology|February 21, 2025

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trialAgata Blasiak, Anh T L Truong, Nigel Foo, et al.

European Heart Journal. Digital Health|January 24, 2024

CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)Anh T L Truong, Shi-Bei Tan, Golda Z Wang, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

NPJ Digital Medicine|August 27, 2024

Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.

Bioengineering & Translational Medicine|May 19, 2025

AI-assisted warfarin dose optimisation with CURATE.AI for clinical impact: Retrospective data analysisTiffany Rui Xuan Gan, Lester W J Tan, Mathias Egermark, et al.

NPJ Precision Oncology|February 21, 2025

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trialAgata Blasiak, Anh T L Truong, Nigel Foo, et al.

European Heart Journal. Digital Health|January 24, 2024

CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)Anh T L Truong, Shi-Bei Tan, Golda Z Wang, et al.

Pageof 1